Shield Therapeutics plc
Helping patients become people again
71 employees · est. 2008 · United Kingdom
MethylGene is the older company (1997 vs 2008).
Side-by-Side Comparison
| Metric | MethylGene | Shield Therapeutics plc |
|---|---|---|
| Founded | ||
| Founded | 1997 older | 2008 |
| Headquarters | ||
| Headquarters | Not tracked yet | United Kingdom |
| Employees | ||
| Employees | Not tracked yet | 71 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $71.83M | $33.20M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Clinical Stage, Cancer Therapeutics, Kinase Inhibitors, HDAC Inhibitors, Oncology, Pharmaceutical Research, Clinical Trials, Drug Development, Neurodegenerative Diseases, Publicly Traded, Oncology Treatments, MethylGene Inc., Taiho Pharmaceutical Co. Ltd. | Specialty Pharmaceuticals, Iron Deficiency, Accrufer, Feraccru, Global Pivotal Phase III Studies, Inflammatory Bowel Disease, Chronic Kidney Disease, Switzerland, Independent Pharmaceutical Company, Global Commercialization, Mineral-derived Hospital Pharmaceuticals, Norgine B.V., Beijing Aosaikang Pharmaceutical Co., Ltd., Korea Pharma Co., Ltd., KY Pharmaceuticals Inc. |
| Website | ||
| Website | methylgene.com | shieldtherapeutics.com |
About MethylGene
MethylGene is a clinical stage biopharmaceutical company dedicated to the development and commercialization of innovative therapeutics primarily targeting cancer. Founded in 1997, it trades on the public market under the symbol TSX:MYG. The company's product portfolio includes MGCD265, an oral, mult...
About Shield Therapeutics plc
Shield Therapeutics plc is a UK-based specialty pharmaceutical company that focuses on addressing iron deficiency through its lead product, Accrufer®/Feraccru® (ferric maltol). The company has already launched Accrufer® in the US, while Feraccru® is commercialized in the UK and European Union by Nor...
We will tell you when either one moves
BounceWatch watches MethylGene and Shield Therapeutics plc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MethylGene and Shield Therapeutics pl... — by email.
Frequently Asked Questions
Compare MethylGene with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at MethylGene on 19 Jun 2024, and Shield Therapeutics plc on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.